Search Results - "Gurland, H J"

Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure by Gawaz, M, Fateh-Moghadam, S, Pilz, G, Gurland, H J, Werdan, K

“…This study focuses on the role of platelet membrane glycoproteins and platelet-leucocyte adhesion in patients with sepsis and multiple organ failure (MOF)…”
Get more information

Lipid apheresis by hemoperfusion: in vitro efficacy and ex vivo biocompatibility of a new low-density lipoprotein adsorber compatible with human whole blood by Bosch, T, Schmidt, B, Blumenstein, M, Gurland, H J

“…To date, selective extracorporeal low-density lipoprotein (LDL) removal can only be performed from plasma; that is, a plasma-cell separation step using a…”
Get more information

Impaired function of platelet membrane glycoprotein IIb-IIIa in end-stage renal disease by Gawaz, M P, Dobos, G, Späth, M, Schollmeyer, P, Gurland, H J, Mujais, S K

“…Impaired platelet function and a bleeding tendency are well-recognized complications of chronic renal failure. Because the fibrinogen receptor GPIIb-IIIa plays…”
Get full text

LDL Hemoperfusion-A New Procedure for LDL Apheresis: First Clinical Application of an LDL Adsorber Compatible with Human Whole Blood by Bosch, T., Schmidt, B., Kleophas, W., Gillen, C., Otto, V., Passlick-Deetjen, J., Gurland, H.J.

“…: To date, lipid apheresis procedures can remove low‐density lipoprotein (LDL) cholesterol (LDL‐C) only from plasma. Thus, initially plasma has to be separated…”
Get full text

Platelet-leukocyte aggregation during hemodialysis by Gawaz, Meinrad P., Mujais, Salim K., Schmidt, Bärbel, Gurland, Hans J.

“…Platelet-leukocyte aggregation during hemodialysis. Hemodialysis is associated with simultaneous changes in leukocytes and platelets, but it is unclear whether…”
Get full text

A comparison of dialysers with low-flux membranes: significant differences in spite of many similarities by WARD, R. A, BUSCAROLI, A, SCHMIDT, B, STEFONI, S, GURLAND, H. J, KLINKMANN, H

“…The solute removal characteristics and haemocompatibility of low-flux dialysers containing Cuprophan, cellulose acetate, polymethylmethacrylate (PMMA), and…”
Get full text

Severity of multiple organ failure (MOF) but not of sepsis correlates with irreversible platelet degranulation by GAWAZ, M, FATEH-MOGHADAM, S, PILZ, G, GURLAND, H.-J, WERDAN, K

“…Multiple hemostatic changes occur in sepsis and multiple organ failure (MOF). To evaluate the role of platelets in patients with sepsis and MOF, we examined…”
Get full text

Biocompatibility of a new high-permeability modified cellulose membrane for haemodialysis by Ward, R A, Schaefer, R M, Falkenhagen, D, Joshua, M S, Heidland, A, Klinkmann, H, Gurland, H J

“…The biocompatibility and solute permeability characteristics of a high-permeability modified cellulose membrane (Hemophan-HP) (He-HP) were compared with those…”
Get more information

Long-term efficiency, biocompatibility, and clinical safety of combined simultaneous LDL-apheresis and haemodialysis in patients with hypercholesterolaemia and end-stage renal failure by Bosch, T, Thiery, J, Gurland, H J, Seidel, D

“…Three hypercholesterolaemic patients on maintenance haemodialysis with angiographically proven coronary artery disease were treated in a once-a-week schedule…”
Get more information

Synthetic modification of PAN membrane: biocompatibility and functional characterization by Mujais, S K, Schmidt, B, Hacker, H, Opatrny, K, Gurland, H J

“…A disturbing interaction of PAN membranes and the bradykinin generation system particularly in the presence of angiotensin converting enzyme inhibitors has…”
Get more information

Efficacy of lipid apheresis: definitions and influencing factors by Bosch, T, Seidel, D, Gurland, H J

“…The comparison of efficiency of currently available lipid apheresis systems has been hampered by different definitions of efficacy and poorly controlled…”
Get more information

Prevention of blood loss in dialysers with DEAE-cellulose membranes does not require increased doses of heparin by Ward, R A, Schmidt, B, Gurland, H J

“…Binding of heparin to DEAE-cellulose membranes may reduce bioavailable heparin, thus increasing the amount of heparin needed for anticoagulation during…”
Get more information

Altered interleukin-1 production in patients undergoing hemodialysis by Blumenstein, M, Schmidt, B, Ward, R A, Ziegler-Heitbrock, H W, Gurland, H J

“…The capacity of peripheral blood mononuclear cells (PBMC) to undergo spontaneous and induced interleukin-1 (IL-1) production was examined in 10 healthy…”
Get more information

Evaluation of phagocytic cell function in an ex vivo model of hemodialysis by Ward, Richard A., Schmidt, Bärbel, Blumenstein, Matthias, Gurland, Hans J.

“…Evaluation of phagocytic cell function in an ex vivo model of hemodialysis. An ex vivo model of hemodialysis was used to evaluate the effect of dialysis…”
Get full text

MRP8/14-positive macrophages as early acute cellular rejection markers, and soluble MRP8/14 and increased expression of adhesion molecules following renal transplantation by Burkhardt, K, Bösnecker, A, Hillebrand, G, Hofmann, G O, Schneeberger, H, Burmeister, G, Land, W, Gurland, H J

Get more information

Analysis of macrophage subsets in renal allograft biopsies with new monoclonal antibodies by Burkhardt, K, Sorg, C, Andreesen, R, Mues, B, Hammer, C, Land, W, Gurland, H J

Get more information

Differential activation of monocytes in haemodialysis patients exposed to different types of membranes by Blumenstein, M, Ziegler-Heitbrock, H W, Schiller, B, Schmidt, B, Ward, R A, Gurland, H J

“…Peripheral blood mononuclear cells (PBMC) from haemodialysis patients treated with different types of membranes were isolated, incubated in vitro, and…”
Get more information

Therapeutic apheresis update by Gurland, H J

Get more information

Measurement of backfiltration rates during hemodialysis with highly permeable membranes by Leypoldt, J K, Schmidt, B, Gurland, H J

“…A method for determining local transmembrane fluid movement in a commercial hemodialyzer at low dialysate flow rates by measuring changes along the dialyzer…”
Get more information

Recombinant human erythropoietin in nephrology by Samtleben, W, Ivanovich, P, Gurland, H J

“…rEPO therapy provides a unique opportunity to correct anemia in end-stage renal failure patients. Complete correction of the anemia, although possible, has…”
Get more information